Effect of combined or separate administration of piracetam and choline on learning and memory in the rat

Abstract

Different groups of rats received combined or separate administration of different doses of piracetam (P1:100, P2:200, and P4:400 mg/kg) and choline (C1:100 and C2:200 mg/kg). Compared to control treatment, C1 significantly improved performance in a delayed alternation (DA) task, while P1, P2, P4 or P1C1 had no effect. Moreover, rats receiving P2C1 and P4C1 were significantly inferior in acquiring DA to rats receiving the vehicle or separate administration of P1, P2 or C1. The different treatments with combined or separate administration of P and C had no effect on spontaneous locomotor activity and two-way avoidance conditioning. In a recognition-task only groups C1 and P4 were able to discriminate between familiar and new objects. The combined or separate administration of P1 and C1 on NA, DA, DOPAC, 5-HT, 5-HIAA levels, CAT activity and choline uptake were measured in frontal cortex and hippocampus: the only significant effect was a 5-HT increase in the hippocampus of rats treated with C1.

This is a preview of subscription content, log in to check access.

References

  1. Aggleton JP (1985) One-trial object recognition by rats. Q J Exp Psychol 37B:279–294

    Google Scholar 

  2. Aggleton JP, Mishkin M (1983) Visual recognition impairment following medial thalamic lesions in monkeys. Neuropsychologia 21:189–197

    Google Scholar 

  3. Aigner T, Mitchell S, Aggleton J, Delong M, Struble R, Price D, Mishkin M (1984) Effects of scopolamine and physostigmine on recognition memory in monkeys after ibotenic acid injections into the area of the nucleus basalis of Meynert. In: Wurtman RJ, Corkin SH, Crowden JH (eds), Alzheimer's disease: Advances in basic research and therapies. Center for brain sciences and metabolism charitable trust, p 429

  4. Atanackovic D, Simonic A, Roganovic J (1984) Influence of piracetam on active avoidance behaviour in rats. Acta Pharm Jugosl 34:139–142

    Google Scholar 

  5. Bartus RT (1980) Cholinergic drug effect on memory and cognition in animals. In: Poon LW (ed) Aging in the 1980 s: Psychological issues. American Psychological Association, Washington, DC, pp 163–180

    Google Scholar 

  6. Bartus RT, Johnson HR (1976) Short-term memory in the rhesus monkey: disruption from the anticholinergic scopolamine. Pharmacol Biochem Behav 5:39–46

    Google Scholar 

  7. Bartus RT, Dean RL (1985) Developing and utilizing animal models in the search for an effective treatment for age-related memory disturbances. In: Gottfries CG (ed) Normal aging, Alzheimer's disease and senile dementia. University of Brussels Press, pp 231–267

  8. Bartus RT, Dean RL, Goas JA, Lippa AS (1980) Age-related changes in passive avoidance retention: Modulation by dietary choline. Science 209:301–303

    Google Scholar 

  9. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric dysfunction: jtA critical review. Science 217:408–417

    Google Scholar 

  10. Bartus RT, Dean RL, Beer B (1984) Cholinergic precursor therapy for geriatric cognition: its past, its present and a question of its future. In: Ordy JM, Harman D, Alfin-Slater R (eds) Nutrition in gerontology. Raven, New York, pp 191–225

    Google Scholar 

  11. Bartus RT, Dean RL, Sherman KA, Friedman E, Beer B (1981) Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 2:105–111

    Google Scholar 

  12. Beninger RJ, Tighe SA, Jhamandas K (1984) Effects of chronic manipulations of dietary choline on locomotor activity, discrimination learning and cortical acetylcholine release in aging adult Fisher 344 rats. Neurobiol Aging 5:29–34

    Google Scholar 

  13. Beninger RJ, Jhamandas K, Boegman RJ, El-Defrawy SR (1986) Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol Biochem Behav 24:1353–1360

    Google Scholar 

  14. Bierkamper GG, Goldberg AM (1980) Release of acetylcholine from the vascular perfused rat phrenic nerve-hemidiaphragm. Brain Res 202:234–237

    Google Scholar 

  15. Brito GNO, Thomas GJ (1981) T-maze alternation, response patterning and septo-hippocampal circuitry in rats. Behav Brain Res 3:319–340

    Google Scholar 

  16. Brito GNO, Davis BJ, Stopp LC, Stanton ME (1983) Memory and the septo-hippocampal cholinergic system in the rat. Psychopharmacology 81:315–320

    Google Scholar 

  17. Brunello N, Cheney DL, Costa E (1982) Increase in exogenous choline fails to elevate the content or turnover rate of cortical, striatal or hippocampal acetylcholine. J Neurochem 38:1160–1163

    Google Scholar 

  18. Buresova O, Bures J (1982) Radial-maze as a tool for assessing the effect of drugs on the working memory of rats. Psychopharmacology 77:268–271

    Google Scholar 

  19. Buxton DA, Brimblecombe RW, French MC, Redfern PH (1976) Brain acetylcholine concentration and acetylcholinesterase activity in selectively-bred strains of rats. Psychopharmacology 47:97–99

    Google Scholar 

  20. Cherkin A, Flood JF (1983) Remarkable potentiation among memory-enhancing cholinergic drugs in mice. In Intervention in the aging process, Part A: quantitation, epidemiology and clinical research. Liss, New York, pp 225–245

    Google Scholar 

  21. Crook TH (1985) Clinical drug trials in Alzheimer's diseases. Ann NY Acad Sci 444:428–436

    Google Scholar 

  22. Cumin R, Bandle EF, Gamzu E, Haefley WF (1982) Effects of the novel compound Aniracetam (Ro 13–5057) upon impaired learning in rodents. Psychopharmacology 78:104–111

    Google Scholar 

  23. Delacour J (1977) Role of temporal lobe structures in visual short-term memory, using a new test. Neuropsychologia 15:681–684

    Google Scholar 

  24. Delacour J, Coulon JF, David JC, Guenaire C (1983) Brain actopamine and strain differences in avoidance behavior. Brain Res 288:169–176

    Google Scholar 

  25. Driscoll P, Dedeck J, Martin JR, Zivkovic B (1983) Two-way avoidance and acute shock stress induced alterations of regional noradrenergic dopaminergic and serotonergic activity in Roman high- and low-avoidance rats. Life Sci 33:1719–1725

    Google Scholar 

  26. Ferris SH, Sathananthan G, Reisberg B, Gershon S (1979) Long-term choline treatment of memory-impaired elderly. Science 205:1039–1040

    Google Scholar 

  27. Ferris SH, Reisberg B, Crook T, Friedman E, Schneck MK, Mir P, Sherman KA, Corwin J, Gershon S, Bartus RT (1982) Pharmacologic treatment of senile dementia: choline, l-dopa, piracetam and choline plus piracetam. Aging 19:475–481

    Google Scholar 

  28. Flentge F, Van den Berg CJ (1979) Choline administration and acetylcholine in brain. J Neurochem 32:1331

    Google Scholar 

  29. Flood JF, Smith GE, Cherkin A (1985) Memory enhancement: Supra-additive effect of subcutaneous cholinergic drug combinations in mice. Psychopharmacology 86:61–67

    Google Scholar 

  30. Friedman E, Sherman KA, Ferris SH, Reisberg B, Bartus RT, Schneck MK (1981) Clinical response to choline plus piracetam in senile dementia: Relation to red-cell choline level. New Engl J Med 304:1490–1491

    Google Scholar 

  31. Gaffan D, Saunders RC (1985) Running recognition of configural stimuli by fornix transected monkeys. Q J Exp Psychol 37B:61–71

    Google Scholar 

  32. Gaffan D, Gaffan EA, Harrison S (1984) Effects of fornix transection on spontaneous and trained non-matching by monkeys. Q J Exp Psychol 36B:285–303

    Google Scholar 

  33. Gamzu E (1985) Animal behavioral models in the discovery of compounds to treat memory dysfunction. Ann NY Acad Sci 444:370–393

    Google Scholar 

  34. Giurgea EC, Salama M (1977) Nootropic drugs. Prog Neuropsychopharmacol 1:235–247

    Google Scholar 

  35. Giurgea EC, Greindel MG, Preat S, Puigdevall J (1982a) Piracetam compensation of MAM-induced behavioral deficit in rats. Aging 19:281–286

    Google Scholar 

  36. Giurgea EC, Greindl MG, Preat S (1982b) Cholinergic experimental modulation and learning. Abstr E.B.B.S., 2–4 Sept. 1982, Parma, Annual Gen Meeting

  37. Goodnick P, Gershon S (1984) Chemotherapy of cognitive disorders in geriatric subjects. J Clin Psychiatry 45:196–209

    Google Scholar 

  38. Growdon JH, Corkin S, Huff FJ (1985) Clinical evaluation of compounds for the treatment of memory dysfunction. Ann NY Acad Sci 444:437–444

    Google Scholar 

  39. Guenaire C, Delacour J (1985) Differential acquisition of a “Working memory” task by the Roman strains of rats. Physiol Behav 34:705–707

    Google Scholar 

  40. Hepler DJ, Olton DS, Wenk GL, Coyle JT (1985a) Lesions in nucleus basalis magnocellularis and medial septal area of rats produce similar memory impairments. J Neurosci 5:866–873

    Google Scholar 

  41. Hepler DJ, Wenk GL, Cribbs BL, Olton DS, Coyle JT (1985b) Memory impairments following basal forebrain lesions. Brain Res 346:8–14

    Google Scholar 

  42. Hershkowitz M, Heron D, Samuel D, Shinitzky M (1982) The modulation of protein phosphorylation and receptor binding in synaptic membranes by changes in lipid fluidity: implications for ageing. Prog Brain Res 56:419–434

    Google Scholar 

  43. Johns CA, Greenwald BS, Mohs RC, Davis KL (1983) The cholinergic treatment strategy in aging and senile dementia. Psychopharmacol Bull 19:185–197

    Google Scholar 

  44. Kazdova E, Bohac O, Dolezal V, Faber J, Slanska J, Tucek S (1984) Treatment of dementia with high doses of lecithin and piracetam. Activ Nerv Super (Praha) 26:244–245

    Google Scholar 

  45. Ladinsky H, Consolo S, Peri G, Crunelli Y, Samanin R (1977) Pharmacological evidence for a serotonergic-cholinergic link in the stratum. In: Jenden DJ (ed) Cholinergic mechanisms and psychopharmacology. Vol 24: Advances in behavioral biology, Plenum, New York, p 615

    Google Scholar 

  46. Ladinsky H, Consolo S, Pugnetti P (1979) A possible central muscarinic receptor agonist role for choline in increasing rat striatal acetylcholine content. In: Barbeau A, Growdon JH, Wurtman J (eds) Nutrition and the brain, Vol 5: Choline and lecithin in brain disorders. Raven, New York, pp 227–232

    Google Scholar 

  47. Martin JR, Driscoll P, Gentsch C (1984) Differential response to cholinergic stimulation in psychogenetically selected rat lines. Psychopharmacology 83:262–267

    Google Scholar 

  48. Means LW, Franklin RD, Cliett CE (1980) Failure of piracetam to facilitate acquisition or retention in younger or older rats. Exp Aging Res 6:175–180

    Google Scholar 

  49. Mervis RF, Bartus RT (1981) Modulation of pyramidal cell dendrite spine population in aging mouse neocortex: role of dietary choline. J Neuropathol Exp Neurol 68:412–419

    Google Scholar 

  50. Millington WR, Goldberg AM (1982) Precursor dependence of acetylcholine release from rat brain in vitro. Brain Res 243:263–270

    Google Scholar 

  51. Mishkin M, Delacour J (1975) An analysis of short-term visual memory in the monkey. J Exp Psychol: Animal Behav Proc 1:326–334

    Google Scholar 

  52. Mohs RC, Davis KL, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS (1979) Choline chloride treatment defects in the elderly. Am J Psychiatry 136:1275–1277

    Google Scholar 

  53. Mohs RC, Davis KL, Tinklenberg JR, Hollister LE (1980) Choline chloride effects on memory in the elderly. Neurobiol Aging 1:21–25

    Google Scholar 

  54. Muma NA, Rowell PP (1984) Behavioral effects of long-term choline and lecithin treatment in aged mice. IRCS Med Sci 12:1090–1091

    Google Scholar 

  55. Nicolaus BJR (1982) Chemistry and pharmacology of nootropics. Drug Dev Res 2:463–474

    Google Scholar 

  56. Ögren SO, Carlsson S, Bartfai T (1985) Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Psychopharmacology 86:258–264

    Google Scholar 

  57. Oglesby MW, Winter JC (1974) Strychnine sulfate and piracetam: lack of effect on learning in the rat. Psychopharmacologia 36:163–173

    Google Scholar 

  58. Olton DS (1983) Memory functions and the hippocampus. In: Seifert W (ed) Neurobiology of the hippocampus. Academic, New York, p 335–373

    Google Scholar 

  59. Olton DS, Becker JT, Handelmann GE (1979) Hippocampus, space and memory. Behav Brain Res 2:313–322

    Google Scholar 

  60. Palacios JM, Kuhar MJ (1979) Choline: binding studies provide some evidence for a weak, direct agonist action in brain. Mol Pharmacol 16:1084–1088

    Google Scholar 

  61. Pedata F, Moroni F, Banfi S, Pepeu G (1985) Effects of nootropic agents on brain cholinergic mechanisms: Clin Neuropharmacol 7:772–773

    Google Scholar 

  62. Platel A, Jalfre M, Pawelec C, Roux S, Porsolt R (1984) Habituation of exploration activity in mice: effects of combination of piracetam and choline on memory processes. Pharmacol Biochem Behav 21:209–212

    Google Scholar 

  63. Pomara N, Block R, Moore N, Rhiew HB, Berchou R, Stanley M, Gershon S (1984) Combined piracetam and cholinergic precursor treatment for primary degenerative dementia. IRCS Med Sci 12:388–389

    Google Scholar 

  64. Pontecorvo MJ, Evans HL (1985) Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons. Pharmacol Biochem Behav 22:745–752

    Google Scholar 

  65. Poschel BPH, Mariott JG, Gluckman MI (1983) Pharmacology of the cognition activator Pramiracetam (C1–879). Drugs Exp Clin Res 9:853–871

    Google Scholar 

  66. Pugsley TA, Poschel BPH, Downs DA, Shih Y-H, Gluckman MI (1983) Some pharmacological and neurochemical properties of a new cognition activator agent, Pramiracetam (C1–879). Psychopharmacol Bull 19:721–726

    Google Scholar 

  67. Reisberg B, Ferris SH, Schneck MK, Corwin J, Mir P, Friedman E, Sherman KA, McCarthy M, Bartus RT (1982) Piracetam in the treatment of cognitive impairment in the elderly. Drug Dev Res 2:475–480

    Google Scholar 

  68. Ridley RM, Murray TK, Johnson JA, Baker HF (1986) Learning and memory impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res 376:108–116

    Google Scholar 

  69. Ridley RM, Bowes PM, Baker HF, Crow TJ (1984) An involvement of acetylcholine in object discrimination learning and memory in the marmoset. Neuropsychologia 22:253–263

    Google Scholar 

  70. Robinson SE (1983) Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci 32:345–353

    Google Scholar 

  71. Samanin R, Quattrone A, Peri G, Ladinsky H, Consolo S (1978) Evidence of an interaction between serotonergic and cholinergic neurons in the corpus striatum and hippocampus of the rat brain. Brain Res 151:73–82

    Google Scholar 

  72. Sara SJ, David-Remacle M (1974) Recovery from electroconvulsive shock-induced amnesia by exposure to the training environment: Pharmacological enhancement by piracetam. Psychopharmacologia 36:59–66

    Google Scholar 

  73. Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: Animal models for studying effects on cognition. Drug Dev Res 4:567–576

    Google Scholar 

  74. Schneck MK (1983) Nootropics. In: Reisberg B (ed) Alzheimer's diseases. Free, New York

    Google Scholar 

  75. Serby M, Corwin J, Rostrosen J, Ferris SH, Reisberg B, Friedman E, Sherman KA, Jordan B, Bartus RT (1983) Lecithin and piracetam in Alzheimer's disease. Psychopharmacol Bull 19:126–129

    Google Scholar 

  76. Speth RC, Yamamura HI (1979) On the ability of choline and its analogues to interact with muscarinic cholinergic receptors in the rat brain. Eur J Pharmacol 58:197

    Google Scholar 

  77. Thal LJ, Rosen WG, Sharpless NS, Crystal HA (1981) Choline chloride fails to improve cognition in Alzheimer's disease. Neurobiol Aging 2:205–208

    Google Scholar 

  78. Valzelli L, Bernasconi S, Sala A (1980) Piracetam activity may differ according to the age of the recipient mouse. Int Pharmacopsychiatr 15:150–156

    Google Scholar 

  79. Vincent G, Velderese A, Gamzu E (1984) The effects of Aniracetam (Ro 13–5057) and piracetam on the enhancement of memory in mice. Soc Neurosci Abstr 10:258

    Google Scholar 

  80. Wecker L (1986) Neurochemical effects of choline supplementation. Can J Physiol Pharmacol 64:329–333

    Google Scholar 

  81. Winer BJ (1971) Statistical principles in experimental design. McGraw Hill, New York

    Google Scholar 

  82. Woelk H (1979a) Effect of piracetam on the incorporation of 32P into phospholipid of neural and glial cells isolated from rabbit cerebral cortex. Pharmacopsychiatry 12:251–256

    Google Scholar 

  83. Woelk H (1979b) On the influence of piracetam upon neuronal and synaptosomal phospholipase A activity. Arzneimittelforschung 29:615–618

    Google Scholar 

  84. Woelk H, Peiler-Ishikawa K (1978) The action of piracetam on the formation of ethanolamine plasmogen by neuronal microsomes of the developing rat brain. Arzneimittelforschung 28:1752–1756

    Google Scholar 

  85. Wolthuis OL (1971) Experiments with UCB 6215, a drug which enhances acquisition in rats: its effects compared with those of methamphetamine. Eur J Pharmacol 16:283–297

    Google Scholar 

  86. Wurtman RJ, Magil SG, Reinstein DK (1981) Piracetam diminishes hippocampal acetylcholine levels in rats. Life Sci 28:812–814

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Ennaceur.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ennaceur, A., Delacour, J. Effect of combined or separate administration of piracetam and choline on learning and memory in the rat. Psychopharmacology 92, 58–67 (1987). https://doi.org/10.1007/BF00215480

Download citation

Key words

  • Piracetam
  • Choline
  • Piracetam + choline
  • Delayed alternation
  • Two-way avoidance
  • Object recognition
  • 5-HT
  • CAT
  • Choline uptake
  • Rat